A novel multiplex assay combining autoantibodies plus PSA has potential implications for classification of prostate cancer from non-malignant cases

Overview of attention for article published in Journal of Translational Medicine, April 2011

Altmetric Badge

About this Attention Score

In the top 25% of all research outputs scored by Altmetric
Good Attention Score compared to outputs of the same age (72nd percentile)
Above-average Attention Score compared to outputs of the same age and source (56th percentile)

Mentioned by

patent: 2 patents

Citations

dimensions_citation: 48 Dimensions

Readers on

mendeley: 44 Mendeley
citeulike: 1 CiteULike

Summary Patents Dimensions citations

So far, Altmetric has seen 2 patents that reference this research output.

REAGENTS AND METHODS FOR MONITORING BREAST CANCER THERAPY

Application EP-3502701-A2

European Patent Office

REAGENTS AND METHODS FOR MONITORING BREAST CANCER THERAPY

Application WO-2017100620-A1

World Intellectual Property Organisation (WIPO)

This page shows the most recent patents that mention this research output.

Click here to find out how to access more activity.